Indeed, the inhibition of IL-1β or IL-6 signalling has demonstrated efficacy in alleviating neuropathic pain caused by nerve injury, underscoring the crucial involvement of IL-1β and IL-6 in the pathogenesis of neuropathic pain (25). The gene discussed is IL6; the disease is injury.